BIOMAT Database Logo BIOMAT Database Logo

Development of the new acellular recombinant pertussis vaccine. 1994

R Rappuoli, and M Pizza, and A Podda, and M T De Magistris, and C Ceccarini, and L Nencioni
Istituto Ricerche Immunobiologiche Siena Biocine Sclavo S.p.A, Italy.

UI MeSH Term Description Entries
D010566 Virulence Factors, Bordetella A set of BACTERIAL ADHESINS and TOXINS, BIOLOGICAL produced by BORDETELLA organisms that determine the pathogenesis of BORDETELLA INFECTIONS, such as WHOOPING COUGH. They include filamentous hemagglutinin; FIMBRIAE PROTEINS; pertactin; PERTUSSIS TOXIN; ADENYLATE CYCLASE TOXIN; dermonecrotic toxin; tracheal cytotoxin; Bordetella LIPOPOLYSACCHARIDES; and tracheal colonization factor. Bordetella Virulence Factors,Agglutinogen 2, Bordetella Pertussis,Bordetella Virulence Determinant,LFP-Hemagglutinin,LP-HA,Leukocytosis-Promoting Factor Hemagglutinin,Lymphocytosis-Promoting Factor-Hemagglutinin,Pertussis Agglutinins,Agglutinins, Pertussis,Determinant, Bordetella Virulence,Factor Hemagglutinin, Leukocytosis-Promoting,Factor-Hemagglutinin, Lymphocytosis-Promoting,Factors, Bordetella Virulence,Hemagglutinin, Leukocytosis-Promoting Factor,LFP Hemagglutinin,LP HA,Leukocytosis Promoting Factor Hemagglutinin,Lymphocytosis Promoting Factor Hemagglutinin,Virulence Determinant, Bordetella
D010567 Pertussis Vaccine A suspension of killed Bordetella pertussis organisms, used for immunization against pertussis (WHOOPING COUGH). It is generally used in a mixture with diphtheria and tetanus toxoids (DTP). There is an acellular pertussis vaccine prepared from the purified antigenic components of Bordetella pertussis, which causes fewer adverse reactions than whole-cell vaccine and, like the whole-cell vaccine, is generally used in a mixture with diphtheria and tetanus toxoids. (From Dorland, 28th ed) Vaccine, Pertussis
D001886 Bordetella pertussis A species of gram-negative, aerobic bacteria that is the causative agent of WHOOPING COUGH. Its cells are minute coccobacilli that are surrounded by a slime sheath. Bacterium tussis-convulsivae,Haemophilus pertussis,Hemophilus pertussis
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D005814 Genes, Viral The functional hereditary units of VIRUSES. Viral Genes,Gene, Viral,Viral Gene
D006389 Hemagglutinins, Viral Specific hemagglutinin subtypes encoded by VIRUSES. Viral Hemagglutinin,Viral Hemagglutinins,Hemagglutinin, Viral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014614 Vaccines, Synthetic Small synthetic peptides that mimic surface antigens of pathogens and are immunogenic, or vaccines manufactured with the aid of recombinant DNA techniques. The latter vaccines may also be whole viruses whose nucleic acids have been modified. Antigens, Synthetic,Chemical Vaccine,Chemical Vaccines,Immunogens, Synthetic,Molecular Vaccine,Molecular Vaccines,Recombinant Vaccine,Semisynthetic Vaccine,Semisynthetic Vaccines,Synthetic Antigen,Synthetic Vaccine,Synthetic Vaccines,Vaccines, Recombinant,Synthetic Antigens,Synthetic Immunogens,Vaccines, Chemical,Vaccines, Molecular,Vaccines, Semisynthetic,Antigen, Synthetic,Recombinant Vaccines,Vaccine, Chemical,Vaccine, Molecular,Vaccine, Recombinant,Vaccine, Semisynthetic,Vaccine, Synthetic
D015164 Vaccines, Inactivated Vaccines in which the infectious microbial nucleic acid components have been destroyed by chemical or physical treatment (e.g., formalin, beta-propiolactone, gamma radiation) without affecting the antigenicity or immunogenicity of the viral coat or bacterial outer membrane proteins. Inactivated Vaccine,Killed Vaccine,Killed Vaccines,Vaccines, Killed,Inactivated Vaccines,Vaccine, Inactivated,Vaccine, Killed

Related Publications

R Rappuoli, and M Pizza, and A Podda, and M T De Magistris, and C Ceccarini, and L Nencioni
Comparative study of a whole-cell pertussis vaccine and a recombinant acellular pertussis vaccine. The Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine.
June 1994, The Journal of pediatrics,
R Rappuoli, and M Pizza, and A Podda, and M T De Magistris, and C Ceccarini, and L Nencioni
[New acellular pertussis vaccine, containing glucosaminylmuramyldipeptide].
January 2004, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
R Rappuoli, and M Pizza, and A Podda, and M T De Magistris, and C Ceccarini, and L Nencioni
Development of acellular pertussis vaccine in Japan.
April 1988, Acta paediatrica Japonica : Overseas edition,
R Rappuoli, and M Pizza, and A Podda, and M T De Magistris, and C Ceccarini, and L Nencioni
[Prophylaxis of pertussis: development and use of acellular pertussis vaccine].
January 2006, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
R Rappuoli, and M Pizza, and A Podda, and M T De Magistris, and C Ceccarini, and L Nencioni
[Acellular pertussis vaccine].
January 2008, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
R Rappuoli, and M Pizza, and A Podda, and M T De Magistris, and C Ceccarini, and L Nencioni
[Acellular pertussis vaccine].
January 1991, Wiener medizinische Wochenschrift (1946),
R Rappuoli, and M Pizza, and A Podda, and M T De Magistris, and C Ceccarini, and L Nencioni
Pertussis vaccine controversies and acellular pertussis vaccine.
June 2003, Indian journal of pediatrics,
R Rappuoli, and M Pizza, and A Podda, and M T De Magistris, and C Ceccarini, and L Nencioni
Prospects for a new acellular pertussis vaccine.
January 1985, Annales de l'Institut Pasteur. Microbiologie,
R Rappuoli, and M Pizza, and A Podda, and M T De Magistris, and C Ceccarini, and L Nencioni
[Immunomodulation activity of new vaccines for pertussis prophylaxis--acellular pertussis vaccine and adsorbed DPT vaccine with acellular component].
January 2004, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
R Rappuoli, and M Pizza, and A Podda, and M T De Magistris, and C Ceccarini, and L Nencioni
Japanese acellular pertussis vaccine.
January 1986, Annali Sclavo. Collana monografica,
Copied contents to your clipboard!